Part 1 and 2: PharmaDrug CEO Daniel Cohen On Johns Hopkins University Partnership To Evaluate DMT Aug 27, 2021
PharmaDrug Announces Clinical Research Collaboration with The Johns Hopkins University to Evaluate DMT in a Comparative… Aug 25, 2021
PharmaDrug Forms Research Collaboration with Terasaki Institute for Novel Ocular Drug Formulation Program to Deliver DMT… Aug 5, 2021
Pharmadrug Announces Positive Research Results of Cepharanthine to Treat Multiple Cancers Jul 28, 2021